Drug Type ASO |
Synonyms |
Target |
Action inhibitors, modulators |
Mechanism MSH3 gene inhibitors(mutS homolog 3 gene inhibitors), DNA damage modulators, RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Preclinical | United States | - | |
Myotonic Dystrophy | Preclinical | United States | - | |
Spinocerebellar Ataxias | Preclinical | United States | - |